Patents by Inventor Eleni Stathaki

Eleni Stathaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation containing an HMG-COA reductase inhibitor and method for the preparation thereof
    Patent number: 8835486
    Abstract: An improved pharmaceutical formulation for oral administration includes a therapeutically effective quantity of an active ingredient and a stabilizer. The active ingredient is Fluvastatin, or pharmaceutically acceptable salts thereof, and the stabilizer is a mixture of Carrageenans. The stabilizer inhibits isomerization, and/or elimination, and/or oxidation and/or recrystallization of the active ingredient.
    Type: Grant
    Filed: May 12, 2006
    Date of Patent: September 16, 2014
    Inventors: Evangelos Karavas, Efthimios Koutris, Elisavet Ioannidou, Eleni Stathaki, Dimitrios Bikiaris
  • Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof
    Patent number: 8187635
    Abstract: The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a pyrrolidone anticonvulsant agent, and in particular Levetiracetam or a pharmaceutical acceptable salt or derivative thereof, in combination with an effective diluent, such as Dibasic Calcium Phosphate, and additional pharmaceutical excipients, and a process for the preparation thereof by wet granulation.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: May 29, 2012
    Assignee: Pharmathen S.A
    Inventors: Evangelos Karavas, Efthimios Koutris, Dimitrios Bikiaris, Vicky Samara, Ioanna Koutri, Eleni Stathaki
  • Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof
    Publication number: 20110065751
    Abstract: The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a selective estrogen receptor modulator, and especially Raloxifene or a pharmaceutical acceptable salt thereof, in combination with a super disintegrant such as Primojel, and a process for the preparation thereof by wet granulation.
    Type: Application
    Filed: October 16, 2007
    Publication date: March 17, 2011
    Applicant: PHARMATHEN S.A.
    Inventors: Evangelos Karavas, Efthimios Koutris, Dimitrios Bikiaris, Vicky Samara, Anastasia Kalaskani, Eleni Stathaki
  • Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof
    Publication number: 20110033538
    Abstract: The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a pyrrolidone anticonvulsant agent, and in particular Levetiracetam or a pharmaceutical acceptable salt or derivative thereof, in combination with an effective diluent, such as Dibasic Calcium Phosphate, and additional pharmaceutical excipients, and a process for the preparation thereof by wet granulation.
    Type: Application
    Filed: October 16, 2007
    Publication date: February 10, 2011
    Applicant: PHARMATHEN S.A.
    Inventors: Evangelos Karavas, Efthimios Koutris, Dimitrios Bikiaris, Vicky Samara, Ioanna Koutri, Eleni Stathaki
  • PHARMACEUTICAL FORMULATION CONTAINING AN HMG-COA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF
    Publication number: 20100137400
    Abstract: The present invention relates to improved pharmaceutical formulation for oral administration comprising a therapeutically effective quantity of an HMG-CoA reductase inhibitor, and more particularly Fluvastatin, Atorvastatin or salts thereof in combination with a linear sulphated polysaccharide such as Carrageenan and a method for the preparation thereof.
    Type: Application
    Filed: May 12, 2006
    Publication date: June 3, 2010
    Applicant: PHARMATHEN S.A.
    Inventors: Evangelos Karavas, Efthimios Koutris, Elisavet Ioannidou, Eleni Stathaki, Dimitrios Bikiaris